Repurposed Effect of <sup>177</sup>Lu-DOTATATE in the Treatment of Mantle Cell Lymphoma

Repurposed Effect of <sup>177</sup>Lu-DOTATATE in the Treatment of Mantle Cell Lymphoma

Mantle cell lymphoma (MCL) is an uncommon subcategory of non-Hodgkin lymphoma (NHL). Pathogenesis primarily includes overexpression of <i>CCND1</i> and <i>SOX11</i> along with other molecular aberrations. Lutetium <sup>177</sup>Lu-DOTATATE is a radiolabeled somato...

Full description

Bibliographic Details
Main Authors: Mohamad K. Elajami, Lorena P. Burton, Hisham F. Bahmad, Gerard Chaaya, Michael Schwartz
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Current Oncology
Subjects:
DOTATATE
mantle cell lymphoma
carcinoid
drug repurposing
case report
Online Access:https://www.mdpi.com/1718-7729/29/10/594

Internet

https://www.mdpi.com/1718-7729/29/10/594

Similar Items